Caricamento...
Nordihydroguaiaretic Acid, a Cytotoxic IGF-IR/HER2 Inhibitor in Trastuzumab-Resistant Breast Cancer
The majority of patients with HER2-overexpressing metastatic breast cancer who initially respond to the HER2-targeted antibody trastuzumab demonstrate disease progression within one year. The identification of novel agents that effectively inhibit survival of cancer cells that have progressed on tra...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2008
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2586607/ https://ncbi.nlm.nih.gov/pubmed/18645000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-08-0012 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|